PL379628A1 - Nowy sposób syntezy perindoprilu i jego farmaceutycznie dopuszczalnych soli - Google Patents
Nowy sposób syntezy perindoprilu i jego farmaceutycznie dopuszczalnych soliInfo
- Publication number
- PL379628A1 PL379628A1 PL379628A PL37962804A PL379628A1 PL 379628 A1 PL379628 A1 PL 379628A1 PL 379628 A PL379628 A PL 379628A PL 37962804 A PL37962804 A PL 37962804A PL 379628 A1 PL379628 A1 PL 379628A1
- Authority
- PL
- Poland
- Prior art keywords
- perindopril
- pharmaceutically
- synthesis
- acceptable salts
- novel method
- Prior art date
Links
- 230000015572 biosynthetic process Effects 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- IPVQLZZIHOAWMC-QXKUPLGCSA-N perindopril Chemical compound C1CCC[C@H]2C[C@@H](C(O)=O)N(C(=O)[C@H](C)N[C@@H](CCC)C(=O)OCC)[C@H]21 IPVQLZZIHOAWMC-QXKUPLGCSA-N 0.000 title 1
- 229960002582 perindopril Drugs 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Cardiology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Peptides Or Proteins (AREA)
- Indole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03292132A EP1380591B1 (fr) | 2003-08-29 | 2003-08-29 | Nouveau procédé de synthèse du perindopril et de ses sels pharmaceutiquement acceptables |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL379628A1 true PL379628A1 (pl) | 2006-10-30 |
| PL211508B1 PL211508B1 (pl) | 2012-05-31 |
Family
ID=29724624
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL379628A PL211508B1 (pl) | 2003-08-29 | 2004-08-27 | Sposób otrzymywania perindoprilu i jego farmaceutycznie dopuszczalnych soli |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US7534896B2 (pl) |
| EP (1) | EP1380591B1 (pl) |
| JP (1) | JP4331206B2 (pl) |
| CN (1) | CN100383160C (pl) |
| AR (1) | AR045516A1 (pl) |
| AT (1) | ATE310012T1 (pl) |
| AU (1) | AU2004270428B2 (pl) |
| DE (1) | DE60302287T2 (pl) |
| DK (1) | DK1380591T3 (pl) |
| EA (1) | EA008668B1 (pl) |
| ES (1) | ES2252633T3 (pl) |
| HK (1) | HK1096408A1 (pl) |
| MY (1) | MY136638A (pl) |
| NZ (1) | NZ545336A (pl) |
| PL (1) | PL211508B1 (pl) |
| SI (1) | SI1380591T1 (pl) |
| WO (1) | WO2005023842A1 (pl) |
| ZA (1) | ZA200601429B (pl) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1371659B1 (fr) * | 2003-08-29 | 2005-10-12 | Les Laboratoires Servier | Nouveau procédé de synthèse du perindopril et de ses sels pharmaceutiquement acceptables |
| DE602005009918D1 (de) | 2005-01-06 | 2008-11-06 | Ipca Lab Ltd | Verfahren zur Synthese von (2S,3aS,7aS)-1-(S)-Alanyl-octahydro-1H-2-carbonsäurederivaten und Verwendung in der Synthese von Perindopril |
| AU2009263737B2 (en) * | 2008-06-24 | 2013-10-24 | Mylan Laboratories Ltd. | Novel polymorphic forms of Perindopril (L)-Arginine and process for the preparation thereof |
| WO2016178591A2 (en) | 2015-05-05 | 2016-11-10 | Gene Predit, Sa | Genetic markers and treatment of male obesity |
| FR3050380B1 (fr) | 2016-04-20 | 2020-07-10 | Les Laboratoires Servier | Composition pharmaceutique comprenant un betabloquant, un inhibiteur de l'enzyme de conversion et un antihypertenseur ou un ains. |
| JP6753699B2 (ja) * | 2016-05-27 | 2020-09-09 | ミネベアミツミ株式会社 | 転がり軸受 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI1323729T1 (en) * | 2003-03-12 | 2005-02-28 | Les Laboratoires Servier | Method for synthesis of (2S,3aS,7aS)-perhydroindole-2-carboxylic acid and esters thereof derivatives; and use in the synthesis of perindopril |
| ATE294814T1 (de) | 2003-03-12 | 2005-05-15 | Servier Lab | Verfahren für die synthese von perindopril und seiner pharmazeutischen annehmbaren salzen |
| ATE315043T1 (de) * | 2003-06-30 | 2006-02-15 | Servier Lab | Verfahren für die synthese von perindopril und seiner pharmazeutischen annehmbaren salzen |
| EP1371659B1 (fr) * | 2003-08-29 | 2005-10-12 | Les Laboratoires Servier | Nouveau procédé de synthèse du perindopril et de ses sels pharmaceutiquement acceptables |
| SI1380590T1 (sl) * | 2003-08-29 | 2006-12-31 | Servier Lab | Postopek za sintezo perindoprila in njenih farmacevtsko sprejemljivih soli |
| SI1420028T1 (sl) * | 2003-11-19 | 2007-06-30 | Servier Lab | Postopek za sintezo perindoprila in njegovih farmacevtsko sprejemljivih soli |
-
2003
- 2003-08-29 AT AT03292132T patent/ATE310012T1/de active
- 2003-08-29 DK DK03292132T patent/DK1380591T3/da active
- 2003-08-29 ES ES03292132T patent/ES2252633T3/es not_active Expired - Lifetime
- 2003-08-29 SI SI200330124T patent/SI1380591T1/sl unknown
- 2003-08-29 EP EP03292132A patent/EP1380591B1/fr not_active Expired - Lifetime
- 2003-08-29 DE DE60302287T patent/DE60302287T2/de not_active Expired - Lifetime
-
2004
- 2004-08-26 MY MYPI20043495A patent/MY136638A/en unknown
- 2004-08-27 PL PL379628A patent/PL211508B1/pl unknown
- 2004-08-27 WO PCT/FR2004/002197 patent/WO2005023842A1/fr active Application Filing
- 2004-08-27 CN CNB2004800235355A patent/CN100383160C/zh not_active Expired - Fee Related
- 2004-08-27 AU AU2004270428A patent/AU2004270428B2/en not_active Ceased
- 2004-08-27 ZA ZA200601429A patent/ZA200601429B/en unknown
- 2004-08-27 EA EA200600454A patent/EA008668B1/ru not_active IP Right Cessation
- 2004-08-27 JP JP2006524395A patent/JP4331206B2/ja not_active Expired - Fee Related
- 2004-08-27 NZ NZ545336A patent/NZ545336A/en not_active IP Right Cessation
- 2004-08-27 US US10/569,537 patent/US7534896B2/en not_active Expired - Fee Related
- 2004-08-27 AR ARP040103079A patent/AR045516A1/es not_active Application Discontinuation
-
2007
- 2007-02-01 HK HK07101186A patent/HK1096408A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1380591B1 (fr) | 2005-11-16 |
| JP4331206B2 (ja) | 2009-09-16 |
| MY136638A (en) | 2008-11-28 |
| WO2005023842A1 (fr) | 2005-03-17 |
| DE60302287D1 (de) | 2005-12-22 |
| AU2004270428B2 (en) | 2008-08-21 |
| DK1380591T3 (da) | 2006-01-23 |
| CN1835966A (zh) | 2006-09-20 |
| EA200600454A1 (ru) | 2006-08-25 |
| ZA200601429B (en) | 2007-05-30 |
| US7534896B2 (en) | 2009-05-19 |
| AR045516A1 (es) | 2005-11-02 |
| EP1380591A1 (fr) | 2004-01-14 |
| AU2004270428A1 (en) | 2005-03-17 |
| EA008668B1 (ru) | 2007-06-29 |
| US20070010572A1 (en) | 2007-01-11 |
| PL211508B1 (pl) | 2012-05-31 |
| HK1096408A1 (en) | 2007-06-01 |
| NZ545336A (en) | 2009-03-31 |
| ES2252633T3 (es) | 2006-05-16 |
| DE60302287T2 (de) | 2006-08-10 |
| SI1380591T1 (sl) | 2006-02-28 |
| CN100383160C (zh) | 2008-04-23 |
| ATE310012T1 (de) | 2005-12-15 |
| JP2007526902A (ja) | 2007-09-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EG26629A (en) | A new process for the synthesis of pyridopril and its pharmaceutically acceptable salts | |
| HK1089188A1 (en) | Novel method of synthesising perindopril and the pharmaceutically- acceptable salts thereof | |
| HK1089187A1 (en) | Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof | |
| EG24152A (en) | Novel method for the synthesis of s-indoline-2-carboxylic acid and application thereof in synthesis of perindopril | |
| HK1096409A1 (en) | Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof | |
| HK1095839A1 (en) | Method for the synthesis of perindopril and the pharmaceutically-acceptable salts thereof | |
| HK1096408A1 (en) | Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof | |
| PL1753720T3 (pl) | Proces wytwarzania peryndoprylu i jego soli | |
| ZA200601426B (en) | Novel method for the synthesis of perindopril and the pharmaceutically-acceptable salts thereof | |
| AU2003250151A8 (en) | Method for the synthesis of anthracycline-peptide conjugates | |
| HK1086281A1 (en) | Novel method for synthesising perindopril and the pharmaceutically acceptable salt thereof | |
| HK1096406A1 (en) | Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof | |
| HK1096407A1 (en) | Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof | |
| AU2003242867A8 (en) | Process for the synthesis of mosapride | |
| MXPA02004180A (es) | Metodos de sintesis de dl-hidroxi-alquil-fenil amidas. | |
| SI1422236T1 (sl) | Postopek za sintezo perindoprila in njegovih farmacevtsko sprejemljivih soli | |
| AU2003217354A8 (en) | Synthesis of sulfamidates |